PT966968E - Combinacoes terapeuticas compreendendo um modulador de receptor de estrogenio selectivo e prostaglandina e2 - Google Patents
Combinacoes terapeuticas compreendendo um modulador de receptor de estrogenio selectivo e prostaglandina e2Info
- Publication number
- PT966968E PT966968E PT99304374T PT99304374T PT966968E PT 966968 E PT966968 E PT 966968E PT 99304374 T PT99304374 T PT 99304374T PT 99304374 T PT99304374 T PT 99304374T PT 966968 E PT966968 E PT 966968E
- Authority
- PT
- Portugal
- Prior art keywords
- prostaglandine
- comprehending
- compositions
- estrogen receptor
- receptor modulator
- Prior art date
Links
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 title abstract 2
- 229960002986 dinoprostone Drugs 0.000 title abstract 2
- 229940095743 selective estrogen receptor modulator Drugs 0.000 title 1
- 239000000333 selective estrogen receptor modulator Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 4
- 208000036119 Frailty Diseases 0.000 abstract 2
- 206010003549 asthenia Diseases 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 208000001164 Osteoporotic Fractures Diseases 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- GXESHMAMLJKROZ-IAPPQJPRSA-N lasofoxifene Chemical compound C1([C@@H]2[C@@H](C3=CC=C(C=C3CC2)O)C=2C=CC(OCCN3CCCC3)=CC=2)=CC=CC=C1 GXESHMAMLJKROZ-IAPPQJPRSA-N 0.000 abstract 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8946898P | 1998-06-16 | 1998-06-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT966968E true PT966968E (pt) | 2004-08-31 |
Family
ID=22217815
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT99304374T PT966968E (pt) | 1998-06-16 | 1999-06-04 | Combinacoes terapeuticas compreendendo um modulador de receptor de estrogenio selectivo e prostaglandina e2 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6284773B1 (pt) |
| EP (1) | EP0966968B1 (pt) |
| JP (1) | JP2000026298A (pt) |
| AT (1) | ATE265853T1 (pt) |
| BR (1) | BR9904146A (pt) |
| CA (1) | CA2274381C (pt) |
| DE (1) | DE69916932T2 (pt) |
| DK (1) | DK0966968T3 (pt) |
| ES (1) | ES2220005T3 (pt) |
| PT (1) | PT966968E (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1156120B1 (en) * | 2000-05-08 | 2006-11-22 | Pfizer Products Inc. | Enzymatic resolution of selective estrogen receptor modulators |
| IL156533A0 (en) * | 2000-12-21 | 2004-01-04 | Oscar M Bassinson | Personal medication dispensing card |
| CZ2004118A3 (cs) | 2001-07-31 | 2004-09-15 | Pfizer Products Inc. | Farmaceutický prostředek, kit a způsoby zahrnující kombinaci činidla estrogenový agonist/antagonist, estrogenu a progestinu |
| JP6957620B2 (ja) * | 2016-12-01 | 2021-11-02 | アルビナス・オペレーションズ・インコーポレイテッドＡｒｖｉｎａｓ Ｏｐｅｒａｔｉｏｎｓ， Ｉｎｃ． | エストロゲン受容体分解物質としてのテトラヒドロナフタレン誘導体およびテトラヒドロイソキノリン誘導体 |
| US12186359B2 (en) | 2019-06-28 | 2025-01-07 | Dompé Farmaceutici S.P.A. | Composition containing branched-chain amino acids |
| MX2022002415A (es) | 2019-08-26 | 2022-03-22 | Arvinas Operations Inc | Metodos de tratamiento del cancer de mama con derivados de tetrahidronaftaleno como degradadores del receptor de estrogenos. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5552412A (en) | 1995-01-09 | 1996-09-03 | Pfizer Inc | 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis |
| UA51676C2 (uk) * | 1995-11-02 | 2002-12-16 | Пфайзер Інк. | (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція |
| HN1996000101A (es) * | 1996-02-28 | 1997-06-26 | Inc Pfizer | Terapia combinada para la osteoporosis |
| US6124314A (en) * | 1997-10-10 | 2000-09-26 | Pfizer Inc. | Osteoporosis compounds |
-
1999
- 1999-06-04 ES ES99304374T patent/ES2220005T3/es not_active Expired - Lifetime
- 1999-06-04 EP EP99304374A patent/EP0966968B1/en not_active Expired - Lifetime
- 1999-06-04 DK DK99304374T patent/DK0966968T3/da active
- 1999-06-04 DE DE69916932T patent/DE69916932T2/de not_active Expired - Fee Related
- 1999-06-04 AT AT99304374T patent/ATE265853T1/de not_active IP Right Cessation
- 1999-06-04 PT PT99304374T patent/PT966968E/pt unknown
- 1999-06-14 CA CA002274381A patent/CA2274381C/en not_active Expired - Fee Related
- 1999-06-14 JP JP11167503A patent/JP2000026298A/ja active Pending
- 1999-06-16 BR BR9904146-4A patent/BR9904146A/pt not_active Application Discontinuation
- 1999-07-14 US US09/314,371 patent/US6284773B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2000026298A (ja) | 2000-01-25 |
| DK0966968T3 (da) | 2004-08-30 |
| ES2220005T3 (es) | 2004-12-01 |
| DE69916932D1 (de) | 2004-06-09 |
| EP0966968B1 (en) | 2004-05-06 |
| CA2274381A1 (en) | 1999-12-16 |
| BR9904146A (pt) | 2000-05-09 |
| DE69916932T2 (de) | 2005-04-21 |
| EP0966968A1 (en) | 1999-12-29 |
| CA2274381C (en) | 2004-02-10 |
| US6284773B1 (en) | 2001-09-04 |
| ATE265853T1 (de) | 2004-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9714155A (pt) | Prevenção da perda e reposição da massa óssea por certos agonistas de prostaglandina. | |
| YU18400A (sh) | Prostaglanidin agonisti i njihova primena za tretiranje koštanih poremećaja | |
| EP0911321A3 (en) | Compounds for the treatment of osteoporosis | |
| YU7797A (sh) | Kombinovana terapija za osteoporozu | |
| AP9801269A0 (en) | Prostaglandin agonists. | |
| BR9710988A (pt) | Método e compostos moduladores receptores de androgênio | |
| BR9510486A (pt) | Compostos moduladores de receptores de esteróide e métodos | |
| NO20040331L (no) | Legemidler for sykdommer med benmassetap som har Eragonist som den aktive bestanddel | |
| YU75800A (sh) | Terapeutske kombinacije koje sadrže modulator selektivnog estrogen receptora i paratiroidni hormon | |
| PT966968E (pt) | Combinacoes terapeuticas compreendendo um modulador de receptor de estrogenio selectivo e prostaglandina e2 | |
| BR9911324A (pt) | Combinações terapêuticas de moduladores de receptor (seletivo) de estrogênio (serm) e secretagogos de hormÈnio do crescimento (ghs) para o tratamento de fragilidade músculo-esqueletal | |
| BR9811819A (pt) | 2-acilaminopropanaminas como antagonistas receptores de taquicinina | |
| ATE262538T1 (de) | Lhrh-analoga zur behandlung der osteoporose | |
| ECSP982698A (es) | Agonistas de prostaglandinas | |
| ECSP982554A (es) | Agonistas de prostaglandinas | |
| UY26651A1 (es) | Terapia combinada para la osteoporosis | |
| ECSP972347A (es) | Prevencion de la perdida y restauracion de la masa osea por determinados agonistas de prostaglandinas |